Education
About Us
Working with TipRanks
Follow Us
BioLife Solutions (BLFS)
NASDAQ:BLFS
BLFS Analyst Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BLFS Stock 12 Month Forecast
Average Price Target
$31.67
▲(33.57%Upside)
| Highest Price Target$34.00 | Average Price Target$31.67 | Lowest Price Target$30.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$24.5
Hold
3.33%
Upside
Reiterated
06/07/25
The overall score of 58 reflects BioLife Solutions' current financial challenges, such as declining revenue and negative profitability, offset by strong revenue growth and improved operational efficiency as highlighted in the earnings call. Technical indicators suggest a moderately positive outlook, though valuation concerns persist due to negative earnings.
H.C. Wainwright
$30
Buy
26.53%
Upside
Reiterated
05/27/25
Maxim Group
$34
Buy
43.40%
Upside
Reiterated
05/13/25
Lake Street
$30
Buy
26.53%
Upside
Reiterated
05/09/25
Craig-Hallum
$32
Buy
34.96%
Upside
Reiterated
05/09/25
TD Cowen
$31
Buy
30.75%
Upside
Reiterated
05/08/25
KeyBanc
$33
Buy
39.18%
Upside
Reiterated
03/17/25
Benchmark Co.
$30
Buy
26.53%
Upside
Reiterated
03/03/25
Analysts Offer Insights on Healthcare Companies: TG Therapeutics (NASDAQ: TGTX), BioLife Solutions (NASDAQ: BLFS) and Surgery Partners (NASDAQ: SGRY)We are maintaining our Buy rating on BLFS shares at this time due to the recent strong quarterly earnings report as well as promising financial guidance for 2025E.
Northland Securities
$28→$31
Buy
30.75%
Upside
Reiterated
01/08/25
Jefferies
$31
Buy
30.75%
Upside
Assigned
12/16/24
Stephens
$30
Buy
26.53%
Upside
Reiterated
11/15/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$24.5
Hold
3.33%
Upside
Reiterated
06/07/25
The overall score of 58 reflects BioLife Solutions' current financial challenges, such as declining revenue and negative profitability, offset by strong revenue growth and improved operational efficiency as highlighted in the earnings call. Technical indicators suggest a moderately positive outlook, though valuation concerns persist due to negative earnings.
H.C. Wainwright
$30
Buy
26.53%
Upside
Reiterated
05/27/25
Maxim Group
$34
Buy
43.40%
Upside
Reiterated
05/13/25
Lake Street
$30
Buy
26.53%
Upside
Reiterated
05/09/25
Craig-Hallum
$32
Buy
34.96%
Upside
Reiterated
05/09/25
TD Cowen
$31
Buy
30.75%
Upside
Reiterated
05/08/25
KeyBanc
$33
Buy
39.18%
Upside
Reiterated
03/17/25
Benchmark Co.
$30
Buy
26.53%
Upside
Reiterated
03/03/25
Analysts Offer Insights on Healthcare Companies: TG Therapeutics (NASDAQ: TGTX), BioLife Solutions (NASDAQ: BLFS) and Surgery Partners (NASDAQ: SGRY)We are maintaining our Buy rating on BLFS shares at this time due to the recent strong quarterly earnings report as well as promising financial guidance for 2025E.
Northland Securities
$28→$31
Buy
30.75%
Upside
Reiterated
01/08/25
Jefferies
$31
Buy
30.75%
Upside
Assigned
12/16/24
Stephens
$30
Buy
26.53%
Upside
Reiterated
11/15/24
Best Analysts Covering BioLife Solutions
1 Month
xxx
Success Rate
8/13 ratings generated profit
Average Return
+3.33%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 61.54% of your transactions generating a profit, with an average return of +3.33% per trade.
3 Months
xxx
Success Rate
14/17 ratings generated profit
Average Return
+22.70%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 82.35% of your transactions generating a profit, with an average return of +22.70% per trade.
1 Year
Success Rate
10/13 ratings generated profit
Average Return
+29.65%
reiterated a buy rating last month
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +29.65% per trade.
2 Years
xxx
Success Rate
10/13 ratings generated profit
Average Return
+27.64%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +27.64% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BLFS Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Mar 25
Apr 25
May 25
Strong Buy
1
1
0
0
0
Buy
12
18
19
16
15
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
19
19
16
15
Each month's total comprises the sum of three months' worth of ratings.
BLFS Financial Forecast
BLFS Stock Forecast FAQ
What is BLFS’s average 12-month price target, according to analysts?
Based on analyst ratings, BioLife Solutions’s 12-month average price target is 31.67.
What is BLFS’s upside potential, based on the analysts’ average price target?
BioLife Solutions has 33.57% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BLFS a Buy, Sell or Hold?
BioLife Solutions has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
What is BioLife Solutions’s price target?
The average price target for BioLife Solutions is 31.67. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $34.00 ,the lowest forecast is $30.00. The average price target represents 33.57% Increase from the current price of $23.71.
The highest analyst price target is $34.00 ,the lowest forecast is $30.00. The average price target represents 33.57% Increase from the current price of $23.71.
What do analysts say about BioLife Solutions?
BioLife Solutions’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of BLFS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.